Levadex meets goals in Phase III study

(HealthScout) UPDATED 2009-08-18

An orally-inhaled migraine medication called Levadex may help ease symptoms, a new Phase III study suggests. The study, funded by the drugmaker, found that patients who took the medication felt relief from nausea, light and sound sensitivity, and pain when compared to a group who took a placebo. The study's authors say the benefit of the drug is that it is as effective as injected drugs and has fewer side effects than oral triptans.
Read full story >

See all Migraine News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyMigraineConnection.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.

Sign in

MyMigraineConnection.com

Levadex meets goals in Phase III study

People who read this also read...

What the community is saying...

Living with a migraine: the pain, judgment, guilt and frustration

AmyHope